James C Ballenger

Summary

Publications

  1. ncbi request reprint Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety
    James C Ballenger
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    J Clin Psychiatry 65:55-62. 2004
  2. ncbi request reprint Remission rates in patients with anxiety disorders treated with paroxetine
    James C Ballenger
    Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, SC 29401, USA
    J Clin Psychiatry 65:1696-707. 2004
  3. ncbi request reprint The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials
    Richard H Weisler
    University of North Carolina at Chapel Hill, NC, USA
    CNS Spectr 11:788-99. 2006
  4. doi request reprint A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders
    Mark S George
    Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Brain Stimul 1:112-21. 2008
  5. ncbi request reprint Generalized anxiety disorder: comorbidity, comparative biology and treatment
    David J Nutt
    School of Medical Sciences, University of Bristol, UK
    Int J Neuropsychopharmacol 5:315-25. 2002
  6. ncbi request reprint Neural correlates of speech anticipatory anxiety in generalized social phobia
    Jeffrey P Lorberbaum
    Department of Psychiatry and Center for Advanced Imaging, Medical University of South Carolina Charleston MUSC, SC 29425, USA
    Neuroreport 15:2701-5. 2004
  7. ncbi request reprint Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice
    Robert M Post
    Bipolar Collaborative Network, Chevy Chase, Maryland, USA
    CNS Drugs 21:47-71. 2007

Detail Information

Publications7

  1. ncbi request reprint Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety
    James C Ballenger
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    J Clin Psychiatry 65:55-62. 2004
    ....
  2. ncbi request reprint Remission rates in patients with anxiety disorders treated with paroxetine
    James C Ballenger
    Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, SC 29401, USA
    J Clin Psychiatry 65:1696-707. 2004
    ..It is proposed that remission is the appropriate target in the treatment of both depression and the anxiety disorders...
  3. ncbi request reprint The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials
    Richard H Weisler
    University of North Carolina at Chapel Hill, NC, USA
    CNS Spectr 11:788-99. 2006
    ..This article provides an overview of data on the use of AEDs in bipolar disorder, including acute mania and depression, prophylaxis, and rapid cycling...
  4. doi request reprint A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders
    Mark S George
    Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Brain Stimul 1:112-21. 2008
    ....
  5. ncbi request reprint Generalized anxiety disorder: comorbidity, comparative biology and treatment
    David J Nutt
    School of Medical Sciences, University of Bristol, UK
    Int J Neuropsychopharmacol 5:315-25. 2002
    ..Finally, current pharmacological and non-pharmacological treatment options for GAD are reviewed, with particular attention being paid to published clinical-trial data...
  6. ncbi request reprint Neural correlates of speech anticipatory anxiety in generalized social phobia
    Jeffrey P Lorberbaum
    Department of Psychiatry and Center for Advanced Imaging, Medical University of South Carolina Charleston MUSC, SC 29425, USA
    Neuroreport 15:2701-5. 2004
    ..Phobics may become so anxious, they cannot think clearly or vice versa...
  7. ncbi request reprint Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice
    Robert M Post
    Bipolar Collaborative Network, Chevy Chase, Maryland, USA
    CNS Drugs 21:47-71. 2007
    ..More precise clinical and biological predictors and correlates of individual clinical responsiveness to carbamazepine and other mood stabilisers are eagerly awaited...